Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health.

Peng J, Yuan JP, Wu CF, Wang JH. · 2011

Read Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health. by Peng J, Yuan JP, Wu CF, Wang JH. (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3210606.txt.

Introduction

Juan Peng and colleagues reviewed fucoxanthin, a pigment from brown seaweeds and diatoms, in this 2011 article in Marine Drugs. The compound colors brown algae and has drawn attention for possible health benefits. The authors summarize the scientific literature on how the body handles fucoxanthin and what effects it may have.

Reported activities include antioxidant, anti-inflammatory, anticancer, anti-obesity, and antidiabetic effects, along with protection for the liver, brain blood vessels, bones, skin, and eyes. One problem is absorption: the human body takes up little fucoxanthin from seaweed on its own. Eating it with oil or fat appears to improve uptake, which the authors say could make it a promising marine-derived drug candidate.

Catalog record

CREATORPeng J, Yuan JP, Wu CF, Wang JH.
YEAR2011
COLLECTIONPAPERS
FORMATTXT
FILE SIZE76 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3210606

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human Health By Juan Peng, Jian-Ping Yuan, Chou-Fei Wu, Jiang-Hai Wang Published in: Marine Drugs DOI: 10.3390/md9101806 ABSTRACT Abstract The marine carotenoid fucoxanthin can be found in marine brown seaweeds, the macroalgae, and diatoms, the microalgae, and has remarkable biological properties. Numerous studies have shown that fucoxanthin has considerable potential and promising applications in human health. In this article, we review the current available scientific literature regarding the metabolism, safety, and bioactivities of fucoxanthin, including its antioxidant, anti-inflammatory, anticancer, anti-obese, antidiabetic, antiangiogenic and antimalarial activities, and its protective effects on the liver, blood vessels of the brain, bones, skin, and eyes. Although some studies have shown the bioavailability of fucoxanthin in brown seaweeds to be low in humans, many studies have suggested that a dietary combination of fucoxanthin and edible oil or lipid could increase the absorption rate of fucoxanthin, and thus it might be a promising marine drug. Keywords: fucoxanthin, metabolite, bioactivity, brown seaweed, diatom 1. INTRODUCTION Fucoxanthin is one of the most abundant carotenoids, and contributes more than 10% of the estimated total production of carotenoids in nature, especially in the marine environment [1]. Fucoxanthin is an orange-colored pigment, along with chlorophylls a and c and β-carotene, present in Chromophyta (Heterokontophyta or Ochrophyta), including brown seaweeds (Phaeophyceae) and diatoms (Bacillariophyta) [2,3]. Fucoxanthin was first isolated from the marine brown seaweeds Fucus, Dictyota, and Laminaria by Willstätter and Page [4] in 1914. The complete structure (Figure 1) of fucoxanthin including chirality was determined by Englert et al. [5]. Some brown seaweeds are the most common edible macroalgae in South-East Asia and a few European countries [6]. Diatoms are unicellular planktonic microalgae and exhibit a characteristic golden-brown color due to a high amount of fucoxanthin that plays a major role in the light-harvesting complex of photosystems [7]. [Figure: Structures of fucoxanthin and its metabolites fucoxanthinol, amarouciaxanthin A, and halocynthiaxanthin.] Fucoxanthin has been isolated for its bioactivity studies from the marine brown seaweeds Alaria crassifolia [8], Cladosiphon okamuranus [9], Cystoseira hakodatensis [8,10], Eisenia bicyclis [8], Fucus serratus [11], Fucus vesiculosus [12], Hijikia fusiformis [13,14], Ishige okamurae [15], Kjellmaniella crassifolia [8], Laminaria japonica [16–18], Laminaria ochotensis [18], Myagropsis myagroides [19], Padina tetrastromatica [6], Petalonia binghamiae [20], Sargassum fulvellum [14], Sargassum heterophyllum [21], Sargassum horneri [10], Sargassum siliquastrum [22], and Undaria pinnatifida [10,14,23–32], and the diatoms Chaetoseros sp. [33,34], Cylindrotheca closterium [35], Odontella aurita [36], and Phaeodactylum tricornutum [2]. Fucoxanthin has remarkable biological properties based on its unique molecular structure similar to neoxanthin, dinoxanthin, and peridinin, which is different from that of other carotenoids such as β-carotene and astaxanthin. Fucoxanthin has an unusual allenic bond and some oxygenic functional groups such as epoxy, hydroxyl, carbonyl and carboxyl moieties in its molecule (Figure 1) that contribute to its unique structure [2,14]. The allenic bond was found mainly in carotenoids such as fucoxanthin, which was the first allenic carotenoid found in brown seaweeds [1], and was responsible for the higher antioxidant [27]. This article reviews the current available scientific literature regarding the metabolism, safety, and bioactivities of fucoxanthin, including its antioxidant, anti-inflammatory, anticancer, anti-obese, antidiabetic, antiangiogenic and antimalarial activities, and its protective effects on the liver, blood vessels of the brain, bones, skin, and eyes. 2. BIOAVAILABILITY, METABOLISM, AND SAFETY OF FUCOXANTHIN 2.1. Bioavailability and Metabolism of Fucoxanthin Solubilization of carotenoids in mixed micelles is considered to be requirement for absorption by intestinal cells. Sugawara et al. [37] demonstrated that phospholipids had intense effects on carotenoid absorption, and the cellular absorption was dependent on the lipophilicity of carotenoids. This study suggested that pancreatic phospholipase A2 and lysophosphatidylcholine were crucial in modulating the absorption of carotenoids in the gastrointestinal tract and supported a simple diffusion mechanism for carotenoid assimilation by the intestinal epithelium. It was suggested that fucoxanthin was more readily absorbed than lutein esters in mouse intestine [38] and its metabolites were accumulated in the body at a higher ratio than astaxanthin [39]. It had been previously reported that ingested fucoxanthin was totally deacetylated in the instestinal lumen and transported via blood in White leghorn laying hens fed the brown seaweed F. serratus, and thus fucoxanthinol was present as one of the main carotenoids in egg yolk [11]. Sugawara et al. [40] showed that fucoxanthin was hydrolyzed to fucoxanthinol during the uptake by differentiated Caco-2 cells, a tissue culture model for studying the absorption of dietary compounds by human intestinal epithelium. This study also showed fucoxanthinol appeared in mouse plasma after ingestion of fucoxanthin, indicating that dietary fucoxanthin was deacetylated into fucoxanthinol in the intestinal tract by lipase and esterase from the pancreas or in intestinal cells, and incorporated as fucoxanthinol from the digestive tract into the blood circulation system in mammals. Therefore, the bioavailability of fucoxanthinol is higher than that of fucoxanthin in the body [41]. Asai et al. [42] investigated further biotransformation of fucoxanthinol in ICR mice and HepG2 cells, and revealed that an unknown metabolite had been previously found in marine tunicate Amaroucium pliciferum, and thus was identified as amarouciaxanthin A (Figure 1). The bioconversion of fucoxanthinol into amarouciaxanthin A through dehydrogenation/isomerization was principally shown in liver microsomes, and fucoxanthinol supplemented to culture medium via HepG2 cells was also converted into amarouciaxanthin A. Therefore, it was suggested that fucoxanthin was converted to fucoxanthinol in the gastrointestinal tract and was then metabolized to amarouciaxanthin A in the liver [6,10,39,42–44], and no fucoxanthin was detected in plasma and liver [42,44]. Hashimoto et al. [39] found that fucoxanthinol and amarouciaxanthin A were detectable in plasma, erythrocytes, the liver, lungs, kidney, heart, spleen, and adipose tissue in ICR mice fed 160 nmol fucoxanthin, whereas no fucoxanthin was detected in these tissues or in the blood. However, the daily oral administration of fucoxanthin for 1 week showed that a small amount of fucoxanthin was not metabolized and was detectable in the liver, lung, kidney, heart, spleen, and adipose tissue of the mice [39]. The percentage of fucoxanthin, fucoxanthinol, and amarouciaxanthin A to the sum of all of these in the adipose tissue was 13, 32, and 55%, respectively, while the percentage in the other tissues was 1–11, 63–76 and 20–26%, respectively [39], indicating that amarouciaxanthin A accumulated preferentially in the adipose tissue [10,38,39], while fucoxanthinol accumulated mainly in the liver, lungs, kidney, heart, and spleen [39]. Yonekura et al. [38] showed that fucoxanthinol and amarouciaxanthin A accumulated mainly in adipose tissues (3.13–3.64 μmol/kg), in which the contents were 2.2- to 2.6-fold of that in plasma, liver, and kidney (1.29–1.80 μmol/kg) in ICR mice fed 128 nmol fucoxanthin daily for 14 days. Further transformation of amarouciaxanthin A to more polar metabolites might be taking place in ICR mice [38]. Sangeetha et al. [6] reported in detail on various metabolites of fucoxanthin besides the major metabolites fucoxanthinol and amarouciaxanthin A in rats, proposed a possible metabolic pathway of fucoxanthin in the plasma and liver of rats, and speculated that these metabolites might be formed as a result of enzymatic reactions such as isomerization, dehydrogenation, deacetylation, oxidation, and demethylation. In addition, in marine animals such as oysters and clams [45–47], fucoxanthinol was further metabolized into halocynthiaxanthin (Figure 1), which was first isolated from sea squirt

Read the complete text